GLP-1 (9-36) amide metabolite suppression of glucose production in isolated mouse hepatocytes

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme
Eva TomasJoel F Habener

Abstract

The glucoincretin hormone glucagon-like peptide-1 (GLP-1) augments glucose-stimulated insulin secretion and is in use as an effective treatment for diabetes. However, after its secretion from the intestine, the insulinotropic GLP-1 (7-36) amide hormone is rapidly inactivated by enzymatic cleavage by the diaminopeptidyl peptidase-4 giving rise to GLP-1 (9-36) amide. Inasmuch as most of the circulating GLP-1 is in the form of the metabolite GLP-1 (9-36) amide it has been suggested that it has insulin-like actions on peripheral insulin-sensitive tissues. In earlier studies, infusions of GLP-1 (9-36) amide in obese insulin-resistant subjects showed a marked suppression of hepatic glucose production. However, it remained uncertain whether the effects on glucose production were due to direct effects on hepatocytes, involved central or portal vein-mediated actions, or were mediated by insulin secretion. Here we show that GLP-1 (9-36) amide directly suppresses glucose production in isolated mouse hepatocytes ex vivo independent of the GLP-1 receptor. These findings support direct insulinomimetic actions of the GLP-1 metabolite on gluconeogenesis in hepatocytes that are independent of insulin action and the GLP-1 receptor, and suggest t...Continue Reading

Citations

Jun 4, 2011·Breast Cancer Research and Treatment·Hagai LigumskyTami Rubinek
Feb 11, 2012·Endocrine Reviews·John R Ussher, Daniel J Drucker
Mar 15, 2012·The Journal of Endocrinology·Zhengu LiuJoel F Habener
Oct 30, 2010·Expert Opinion on Biological Therapy·Michael J Riedel, Timothy J Kieffer
Dec 25, 2012·Trends in Endocrinology and Metabolism : TEM·Joel F Habener, Violeta Stanojevic
Nov 3, 2015·Peptides·Flavio FranciniJuan José Gagliardino
Mar 5, 2014·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Heather EngAmit S Kalgutkar
May 22, 2016·Clinical Biochemistry·Robert I OsborneRobert J Konrad
Aug 11, 2016·American Journal of Physiology. Endocrinology and Metabolism·Tianru Jin, Jianping Weng
Aug 2, 2013·Nature Reviews. Drug Discovery·Denise WoottenPatrick M Sexton
May 11, 2019·The Journal of Clinical Endocrinology and Metabolism·Nicolai J Wewer AlbrechtsenPeter Plomgaard
Sep 24, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Raman SharmaAmit S Kalgutkar
May 12, 2012·Molecular Pharmacology·Denise WoottenPatrick M Sexton
Apr 20, 2017·American Journal of Physiology. Endocrinology and Metabolism·Nicolai J Wewer AlbrechtsenBolette Hartmann
May 4, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Huashan GaoLiang Jin
Jul 3, 2017·Diabetologia·Johanne A WindeløvJens J Holst
Jan 4, 2017·Eating and Weight Disorders : EWD·Valeria Guglielmi, Paolo Sbraccia
Dec 12, 2018·Frontiers in Endocrinology·Jordan RowlandsRodrigo Carlessi
May 16, 2017·European Journal of Pharmacology·Gabriele Catyana KrauseJarbas Rodrigues de Oliveira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.